Clinical Trial Update: Offering Influenza and Pneumococcal Vaccine to Patients Being Evaluated in the Emergency Department [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial update describes offering influenza and pneumococcal vaccines to patients evaluated in the emergency department, sponsored by Louisi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia

Drugs mentioned

• Influenza vaccine (influenza vaccine)
• Pneumococcal vaccine (pneumococcal vaccine)

Snippet

Sponsor: Louisiana State University Health Sciences Center in New Orleans | Conditions: High Risk for Serious Influenza, High Risk for Pneumonia | Phase 2 | Status: UNKNOWN